Full Text View
Tabular View
No Study Results Posted
Related Studies
"The Evaluation of Stimulant Withdrawal" (MARC)
This study has been withdrawn prior to enrollment.
( This study was withdrawn for lack of progress. No subjects were recruited. )
Study NCT00442923   Information provided by National Institute on Drug Abuse (NIDA)
First Received: March 2, 2007   Last Updated: December 3, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anxiety
Relapse
Substance Addiction
Additional conditions recognized in this trial
Behavior, Addictive
Recurrence
Substance-Related Disorders
More general conditions related to this trial
Compulsive Behavior
Disease Attributes
Disorders of Environmental Origin
Impulsive Behavior
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Coreg
Additional drug interventions recognized in this trial
Amphetamine
Methamphetamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services